Scientists uncover the promise of mesenchymal stem cells (MSCs), also known as medicinal signaling cells, to modulate the immune system and regenerate tissue.

The sponsors of upwards of 1,000 clinical trials may be forced to publish data that have gone unpublished over a 10-year period.

The widely expected move comes months after the companies scrapped trials of another Alzheimer’s drug.

The drug promotes and sustains brain cell connectivity in mice, reversing the effects of chronic stress.

A prototype in-vein device would collect toxic medications before they reach healthy tissues.

This year’s winners are C. David Allis, Michael Grunstein, John Glen, and Joan Steitz.

As the CBD-based medication enters the market, the agency promises a crackdown on producers of cannabidiol products that make unproven claims.

Multidrug combinations lead to better results for cancer patients, but efficiently identifying them is proving difficult.

Researchers use several different strategies to deliver a one-two punch.